In episode 398, James and Mike continue their discussion of the evidence around the class of agents called monoclonal antibodies. In this podcast we focus on medications that have an effect on symptoms and at the end we put the entire class into perspective – at least as much as we can.
In episode 397, James and Mike discuss the evidence around the class of medications called monoclonal antibodies. We talk a little bit about them as a whole and then talk specifically about 6 different agents and the trials that have looked at the effectiveness of these interesting new medications.
In episode 396, Mike and James present PREMIUM information from a premium province (BC). We discuss new studies that looked at measurements of blood pressure and bone density. At the end we put all of this information into a premium perspective.
In episode 395, James and Mike bring in Adrienne to chew and digest all the evidence around the ketogenic diet. At the end we realize we will likely never have definitive evidence around these diet issues so we all commiserate by drowning our sorrows in a large helping of deep fried Mars Bars.
In episode 393, James and Mike bring in Tina to deal with the issue of the evidence around CPAP. We find out that there is little evidence that CPAP reduces CVD so it is all about does the person feel better while on it – over and above the nuisance and cost.
In episode 392, James and Mike get back to work after a European tour and other reasons. We go over the results from the latest large aspirin trials and, low and behold, the results show pretty much what we already knew.
In episode 391, Mike and James have yet again a PREMIUM moment that will leave you short of breath. We go over 2 new studies that looked at asthma action plans and does increasing doses of inhaled corticosteroids work.